Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2020-02-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19
NCT04385810
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
NCT04387292
Ocular Trauma and COVID-19 in Indonesia
NCT06291844
Validation of a Computerized Triage Algorithm for Ophthalmic Emergencies
NCT03533842
Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence Tomography
NCT01391676
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All demographics and clinical data will be analyzed and compared to evaluate differences and type of accesses.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2020 Lockdown period
Patients who access to Ophthalmological emergency service during lockdown period in 2020
data collection
data collection
2019
Patients who access to Ophthalmological emergency service in 2019 definite periods
data collection
data collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
data collection
data collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
\-
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Università degli Studi dell'Insubria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simone Donati
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ASST Sette Laghi
Varese, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Poyser A, Deol SS, Osman L, Kuht HJ, Sivagnanasithiyar T, Manrique R, Okafor LO, DeSilva I, Sharpe D, Savant V, Sarodia U, Sarvananthan N, Chaudhuri R, Banerjee S, Burns J, Thomas MG. Impact of COVID-19 pandemic and lockdown on eye emergencies. Eur J Ophthalmol. 2021 Nov;31(6):2894-2900. doi: 10.1177/1120672120974944. Epub 2020 Nov 19.
Ehlken C, von Medem C, Ludemann M, Kirsch AM, Roider JB. Patients' perspective on emergency treatment of ophthalmologic diseases during the first phase of SARS-CoV2 pandemic in a tertiary referral center in Germany - the COVID-DETOUR questionnaire study. BMC Ophthalmol. 2021 Aug 16;21(1):301. doi: 10.1186/s12886-021-02054-7.
Salvetat ML, Salati C, Busatto P, Zeppieri M. The impact of COVID-19 related national lockdown on ophthalmic emergency in Italy: A multicenter study. Eur J Ophthalmol. 2022 May;32(3):1782-1794. doi: 10.1177/11206721211028046. Epub 2021 Jul 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02/2021 - COVID and EYE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.